ACELRX PHARMACEUTICALS INC 4
4 · ACELRX PHARMACEUTICALS INC · Filed Sep 18, 2013
Insider Transaction Report
Form 4
Chung David
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2013-09-12+150,000→ 150,000 totalExercise: $10.55From: 2014-09-02Exp: 2023-09-11→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]Issued pursuant to the 2011 Equity Incentive Plan.
- [F2]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (September 2, 2014) and the remaining shares subject to the option vest on an equal monthly basis over the next 36 months.
- [F3]Double Trigger Acceleration upon Change of Control.